VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29

Tuesday, October 14, 2008 General News J E 4
SAN JOSE, Calif., Oct. 13 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices forthe minimally invasive treatment of peripheral vascular disease, announcedtoday that it plans to report its financial results for the third quarterended September 30, 2008, after the close of market on October 29.

VNUS plans to host its regular quarterly teleconference at 2:00 p.m. PT /5:00 p.m. ET on October 29. This call will be webcast live for all investorsand archived on the company's website at

How to Access the Teleconference Webcast

Go to the home page of the VNUS investor relations website at and click on the webcast icon. From this site, you canlisten to the teleconference, assuming that your computer system is configuredproperly.

How to Access the Live Teleconference

Dial-in #: (303) 262-2006. To participate, please dial in approximately5-10 minutes before the teleconference is scheduled to begin. The operatorwill take your name and connect your line with the meeting. A phone replaywill be available for seven days after the live call at (303) 590-3000, code11120881#.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasivetreatment of venous reflux disease, a progressive condition that is often theunderlying cause of painful varicose veins. VNUS sells the Closure(R) system,which consists of a proprietary radiofrequency (RF) generator and proprietarydisposable endovenous catheters and devices to close diseased veins throughthe application of temperature-controlled RF energy. Approximately 300,000patients have been treated to date with VNUS Closure catheters. For moreinformation, please visit the corporate website at .

SOURCE VNUS Medical Technologies, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
NeoVista Presents Anatomic Outcomes of Novel Wet A...
Discovery Health is Expecting! Season Two of DELIV...